General Information of This Metabolic Reaction (MR) (ID:
MR003714) |
Formula |
|
Reactant |
LCZ-696 |
Product |
Sacubitril |
Reactant Info
|
Product Info
|
Metabolic Type
|
Hydrolysis
-
Ester hydrolysis
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects
|
2 |
Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)
|
3 |
Dicarboxylic acid dipeptide neutral endopeptidase inhibitors
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.